back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-08 10:35 Tx date 2025-08-12 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Holder: BMG PHARMA SRL (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
+8,535,625 vol |
8,535,625 | |
| Filed 2026-09-08 10:34 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Holder: BMG PHARMA SRL (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-08 10:33 Tx date 2026-06-09 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
-1,333,333 vol |
2,666,667 | |
| Filed 2026-09-08 10:30 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
4,000,000 | ||
| Filed 2026-09-08 10:26 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,000 vol |
||
| Filed 2026-09-08 10:22 Tx date 2022-09-08 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,000 vol |
340,000 | |
| Filed 2026-09-08 10:20 Tx date 2026-06-09 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+1,176,998 vol |
3,754,477 | |
| Filed 2026-09-08 10:19 Tx date 2026-06-09 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+1,333,333 vol |
2,577,479 | |
| Filed 2026-09-08 10:18 Tx date 2025-03-21 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
1,244,146 | |
| Filed 2026-09-08 10:17 Tx date 2025-03-19 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+80,000 vol |
1,194,146 | |
| Filed 2026-09-08 10:16 Tx date 2025-03-18 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+139,925 vol |
1,114,146 | |
| Filed 2026-09-08 10:09 Tx date 2025-03-17 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+204,015 vol |
974,221 | |
| Filed 2026-09-08 10:08 Tx date 2025-02-28 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
770,206 | |
| Filed 2026-09-08 10:07 Tx date 2025-02-27 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+380,206 vol |
720,206 | |
| Filed 2026-09-08 10:05 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+340,000 vol |
||
| Filed 2026-08-06 03:57 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+3,754,477 vol |
||
| Filed 2026-08-04 21:41 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+3,757,477 vol |
||
| Filed 2026-07-29 18:36 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+2,666,667 vol |
||
| Filed 2026-07-29 18:34 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-29 18:34 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,097,477 vol |
||
| Filed 2025-10-09 21:58 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Holder: BMG PHARMA SRL (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-06 03:57 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+3,754,477 vol |
3,754,477 | |
| Filed 2026-08-04 21:41 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+3,757,477 vol |
||
| Filed 2026-07-29 18:34 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,097,477 vol |
||
| Filed 2026-08-04 21:41 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+3,757,477 vol |
3,757,477 | |
| Filed 2026-07-29 18:34 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,097,477 vol |
||
| Filed 2026-07-29 18:36 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+2,666,667 vol |
2,666,667 | |
| Filed 2026-07-29 18:34 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-29 18:34 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,097,477 vol |
4,097,477 | |
| Filed 2026-07-29 18:33 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-29 18:32 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-29 18:32 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+1,516,998 vol |
||
| Filed 2026-07-29 18:32 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
$66,666
+1,333,333 vol $0.05 each |
||
| Filed 2026-07-24 21:06 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+1,516,998 vol |
||
| Filed 2025-09-22 21:16 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
$66,666
+1,333,333 vol $0.05 each |
||
| Filed 2025-09-22 21:07 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-24 21:06 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+1,516,998 vol |
2,850,331 | |
| Filed 2026-07-24 21:05 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-24 21:04 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+2,850,331 vol |
||
| Filed 2026-07-24 21:03 Tx date 2026-07-24 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+2,850,331 vol |
||
| Filed 2026-07-24 21:00 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-09 21:58 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Holder: BMG PHARMA SRL (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,535,625 | ||
| Filed 2025-09-22 21:16 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
$66,666
+1,333,333 vol $0.05 each |
1,333,333 | |
| Filed 2025-09-22 21:07 Tx date 2025-09-01 |
$LOBE
Lobe Sciences Ltd. |
Mastrodonato, Marco
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|